Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Dalgarno

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Current Pharmaceutical Design|August 13, 2002
Targeting protein kinases for bone disease: discovery and development of Src inhibitorsChester A Metcalf, Marie Rose van Schravendijk, David C Dalgarno, et al.
Biorxiv : the Preprint Server for Biology|August 7, 2023
Predicting Relative Populations of Protein Conformations without a Physics Engine Using AlphaFold 2Gabriel Monteiro da Silva, Jennifer Y Cui, David C Dalgarno, et al.
Arxiv|August 7, 2023
Predicting Relative Populations of Protein Conformations without a Physics Engine Using AlphaFold2Gabriel Monteiro da Silva, Jennifer Y Cui, David C Dalgarno, et al.
Nature Communications|March 28, 2024
High-throughput prediction of protein conformational distributions with subsampled AlphaFold2Gabriel Monteiro da Silva, Jennifer Y Cui, David C Dalgarno, et al.
The Journal of Antibiotics|July 28, 2011
Identification of novel rapamycin derivatives as low-level impurities in active pharmaceutical ingredientsStephan G Zech, Michael Carr, Qurish K Mohemmad, et al.
Chemical Biology & Drug Design|November 10, 2009
Structural analysis of DFG-in and DFG-out dual Src-Abl inhibitors sharing a common vinyl purine templateTianjun Zhou, Lois Commodore, Wei-Sheng Huang, et al.
Current Opinion in Drug Discovery & Development|October 29, 2003
Novel bone-targeted Src tyrosine kinase inhibitor drug discoveryWilliam C Shakespeare, Chester A Metcalf, Yihan Wang, et al.
Blood|October 18, 2003
Pharmacologically regulated Fas-mediated death of adoptively transferred T cells in a nonhuman primate modelCarolina Berger, C Anthony Blau, Meei-Li Huang, et al.
Annals of the New York Academy of Sciences|July 13, 2006
Future anti-catabolic therapeutic targets in bone diseaseBrendan F Boyce, Lianping Xing, Zhenqiang Yao, et al.
Mini Reviews in Medicinal Chemistry|October 9, 2002
SRC homology-2 inhibitors: peptidomimetic and nonpeptideTomi K Sawyer, Regine S Bohacek, David C Dalgarno, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Current Pharmaceutical Design|August 13, 2002
Targeting protein kinases for bone disease: discovery and development of Src inhibitorsChester A Metcalf, Marie Rose van Schravendijk, David C Dalgarno, et al.
Biorxiv : the Preprint Server for Biology|August 7, 2023
Predicting Relative Populations of Protein Conformations without a Physics Engine Using AlphaFold 2Gabriel Monteiro da Silva, Jennifer Y Cui, David C Dalgarno, et al.
Arxiv|August 7, 2023
Predicting Relative Populations of Protein Conformations without a Physics Engine Using AlphaFold2Gabriel Monteiro da Silva, Jennifer Y Cui, David C Dalgarno, et al.
Nature Communications|March 28, 2024
High-throughput prediction of protein conformational distributions with subsampled AlphaFold2Gabriel Monteiro da Silva, Jennifer Y Cui, David C Dalgarno, et al.
The Journal of Antibiotics|July 28, 2011
Identification of novel rapamycin derivatives as low-level impurities in active pharmaceutical ingredientsStephan G Zech, Michael Carr, Qurish K Mohemmad, et al.
Chemical Biology & Drug Design|November 10, 2009
Structural analysis of DFG-in and DFG-out dual Src-Abl inhibitors sharing a common vinyl purine templateTianjun Zhou, Lois Commodore, Wei-Sheng Huang, et al.
Current Opinion in Drug Discovery & Development|October 29, 2003
Novel bone-targeted Src tyrosine kinase inhibitor drug discoveryWilliam C Shakespeare, Chester A Metcalf, Yihan Wang, et al.
Blood|October 18, 2003
Pharmacologically regulated Fas-mediated death of adoptively transferred T cells in a nonhuman primate modelCarolina Berger, C Anthony Blau, Meei-Li Huang, et al.
Annals of the New York Academy of Sciences|July 13, 2006
Future anti-catabolic therapeutic targets in bone diseaseBrendan F Boyce, Lianping Xing, Zhenqiang Yao, et al.
Mini Reviews in Medicinal Chemistry|October 9, 2002
SRC homology-2 inhibitors: peptidomimetic and nonpeptideTomi K Sawyer, Regine S Bohacek, David C Dalgarno, et al.
Pageof 3